Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer (BC): Results from I-SPY 2.
PaperCitations, authors & open-access status
Pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer (BC): Results from I-SPY 2. is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 208 citations, 2017 year and closed oa status.
208
Citations
2017
Year
closed
OA Status